ArticleJournal of fluorescence2026
New Fluorescent Probes for Visual Proteins. Part III. Probing Auxiliary Gateways and the Stepwise Activation Model of Ligand Transport.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents the functional characterisation of auxiliary ligand-transport pathways in bovine visual pigments using the fluorescent probe L1, a synthetic analogue of retinal. While structural studies have identified potential entrance channels Hole A and Hole B, the dynamic 'traffic report' of how these pathways regulate retinoid flux has remained elusive. We utilised the unique photophysical properties of L1, specifically its dual-fluorescence and sensitive response to the local dielectric environment, to probe the subsurface reactive gateways of opsin and rhodopsin. In the rigid, hydrophobic environment of the protein channels, the L1 probe exhibits a significant increase in fluorescence quantum yield, reaching [Formula: see text] in bovine opsin, which represents a significant enhancement relative to the aqueous state. This enhancement is a direct reporter of the mechanical planarisation of the probe, which effectively blocks the non-radiative twisted intramolecular charge-transfer (TICT) state prevalent in fluid solvents. Competitive titration and time-resolved kinetic analysis identify a critical stoichiometric transition in the ligand channelling mechanism. Our results demonstrate that the auxiliary binding sites function as a high-capacity molecular buffer, accommodating up to seven equivalents of the L1 probe without impeding the primary visual cycle. However, exceeding this threshold leads to a distinct 'saturation cliff', where the auxiliary channels become saturated and act as kinetic bottlenecks. At 20 equivalents of L1, the recovery efficiency of native rhodopsin is suppressed to only 10.5%, providing the functional evidence for the gated nature of these pathways. Reciprocal inhibition experiments confirm that L1 and 11-cis-retinal utilise a shared network of subsurface reactive gateways, while the rigid, linear all-trans-retinal and the shorter L2 probe remain excluded due to geometrical selectivity. These findings culminate in the proposal of a stepwise activation model, where the auxiliary sites act as a molecular reservoir that regulates the flux of retinoids into the primary orthosteric pocket. This model provides a robust physical foundation for the memory vision hypothesis, suggesting that the occupancy state of these channels governs the persistence of visual signals following intense light exposure. By contrasting the 'open/gated' architecture of the bovine visual pigments with the 'sealed' and rigid structure of bacteriorhodopsin, we highlight the evolutionary specialisation required for high-efficiency vertebrate vision.
Indexed as
Identifiers
42183998What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.